Connection

Xuping Xie to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Xuping Xie has written about Drug Evaluation, Preclinical.
Xuping Xie
Connection Strength
0.042
Drug Evaluation, Preclinical
  1. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation. Sci Rep. 2021 01 26; 11(1):2229.
    View in: PubMed
    Score: 0.023
  2. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.